Polymer-factor IX moiety conjugates

Details for Australian Patent Application No. 2005260763 (hide)

Owner Nektar Therapeutics

Inventors Stephenson, Gayle; Bossard, Mary J.

Agent Griffith Hack

Pub. Number AU-B-2005260763

PCT Pub. Number WO2006/005058

Priority 60/584,505 30.06.04 US

Filing date 30 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 22 December 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/005058 Priority application(s): WO2006/005058

25 February 2010 Assignment before Grant

  Nektar Therapeutics AL, Corporation The application has been assigned to Nektar Therapeutics

22 December 2011 Application Accepted

  Published as AU-B-2005260763

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260774-Intravaginal device with controlled expansion

2005260761-Inkjet printhead with multiple ink reservoirs